Association of Pulse Dose Corticosteroids With Outcomes Among Patients With Acute Exacerbations of Idiopathic Pulmonary Fibrosis
We observed no significant benefit or harm associated with the receipt of pulse dose corticosteroids for patients with AE-IPF. However, in the subgroup of patients admitted to ICU/intermediate care, there was an increased risk of in-hospital death/discharge to hospice. Future studies should explore the use of pulse vs low-dose corticosteroids in critically ill populations with AE-IPF.
Authors
- Anica C. Law (ORCID: https://orcid.org/0000-0003-3616-0316)
- Allan J. Walkey (ORCID: https://orcid.org/0000-0003-4685-6894)
- Mari‐Lynn Drainoni (ORCID: https://orcid.org/0000-0001-7214-8037)
- Kevin C. Wilson (ORCID: https://orcid.org/0000-0003-4429-2263)
- Finn Hawkins (ORCID: https://orcid.org/0000-0002-2246-6448)
- D. Shankar (ORCID: https://orcid.org/0000-0002-2433-4895)
- Konstantinos–Dionysios Alysandratos (ORCID: https://orcid.org/0000-0002-5611-0343)
- S. Reza Jafarzadeh (ORCID: https://orcid.org/0000-0002-1099-9175)
- Nicholas A. Bosch (ORCID: https://orcid.org/0000-0001-7161-5254)
- Renda Soylemez Wiener (ORCID: https://orcid.org/0000-0001-7712-2135)
Institutions
- Anna Needs Neuroblastoma Answers (US)
Publication Details
- Journal
- CHEST Pulmonary
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1016/j.chpulm.2025.100207
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- NHLBI Division of Intramural Research